Suppr超能文献

新型利尿剂速尿的临床试验:与氢氯噻嗪及汞撒利的比较

Clinical trial of a new diuretic, furosemide: comparison with hydrochlorothiazide and mercaptomerin.

作者信息

Godwin T F, Gunton R W

出版信息

Can Med Assoc J. 1965 Dec 18;93(25):1296-300.

Abstract

A clinical trial was carried out with the object of comparing the effects of furosemide, a new oral diuretic agent, with those of mercaptomerin and hydrochlorothiazide. Eleven edematous patients were chosen for the study and the diuretics were rotated, each drug being preceded by a one- to three-day control period. The patients served as their own controls. Urine electrolytes, body weight, and blood chemistry were monitored.Furosemide was shown to be an effective diuretic in this clinical study; under the conditions of the trial a single oral dose of 80 mg. of furosemide produced a natriuretic response in a 24-hour period equivalent to that achieved with a single oral dose of 100 mg. of hydrochlorothiazide or a single dose of 2.0 c.c. (80 mg. of mercury) of mercaptomerin given intramuscularly.

摘要

进行了一项临床试验,目的是比较新型口服利尿剂速尿与汞撒利和氢氯噻嗪的效果。选择了11名水肿患者进行研究,利尿剂轮流使用,每种药物使用前有1至3天的对照期。患者自身作为对照。监测尿电解质、体重和血液化学指标。在这项临床研究中,速尿被证明是一种有效的利尿剂;在试验条件下,单次口服80毫克速尿在24小时内产生的排钠反应与单次口服100毫克氢氯噻嗪或单次肌肉注射2.0毫升(80毫克汞)汞撒利所产生的排钠反应相当。

相似文献

引用本文的文献

1
Diuretics: a review of the pharmacology and effects on glucose homeostasis.利尿剂:药理学及其对葡萄糖稳态影响的综述
Front Pharmacol. 2025 Mar 28;16:1513125. doi: 10.3389/fphar.2025.1513125. eCollection 2025.
3
Clinical pharmacokinetics of frusemide.
Clin Pharmacokinet. 1979 Jul-Aug;4(4):279-96. doi: 10.2165/00003088-197904040-00002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验